Rumor Suggests BioMap Quietly Files for Hong Kong IPO, Aiming to Raise Billions

Stock News
Mar 16

According to reports, BioMap, a life sciences artificial intelligence (AI) large model company, has confidentially submitted an application for a Hong Kong listing and plans to raise several billion U.S. dollars. The reports indicate that BioMap is working with China International Capital Corporation, Morgan Stanley, and UBS Group on the preparation for this listing. However, related discussions are still ongoing, and details such as the fundraising scale and listing timeline are subject to change. BioMap was jointly founded in 2020 by Baidu co-founder and CEO Robin Li and former Baidu Ventures CEO Wei Liu. The current CEO of BioMap, Wei Liu, stated last May that the company planned to seek a listing in Hong Kong within the next year and a half. Information shows that BioMap, as a pioneer in global foundational large models for life sciences, utilizes a 210-billion-parameter cross-modal biological language model to decode the underlying principles of genomes, proteins, cells, and biological systems, enabling the construction of high-quality life sciences AI task models with less data and lower costs.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10